Literature DB >> 26804566

21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations.

Ruifang Wang1, Yongguo Yu1, Jun Ye1, Lianshu Han1, Wenjuan Qiu1, Huiwen Zhang1, Lili Liang1, Zhuwen Gong1, Lili Wang1, Xuefan Gu2.   

Abstract

Steroid 21-hydroxylase deficiency (21-OHD) caused by the CYP21A2 gene mutations accounts for more than 90% of congenital adrenal hyperplasia (CAH) cases. In this study, molecular defects of 230 patients with 21-OHD were investigated. Point mutations of CYP21A2 gene were analyzed by Sanger sequencing, and large gene deletions were detected by multiplex ligation-dependent probe amplification (MLPA). Nine micro-conversions and 18 spontaneous mutations accounted for 74.6% of alleles, while large gene deletions and large gene conversions accounted for 25.4% of alleles. The most frequent micro-conversion was c.292-13A/C>G (I2G) (35%), followed by p.I173N (14.3%), p.R357W (5.9%) and p.Q319* (4.6%). Nine novel mutations were identified in these patients, which were predicted to hamper the 21-hydroxylase protein function in varying degrees. Genotype and phenotype correlated well in 89.6% of our patients, but disparity in phenotypic appearance also appeared in a small portion of the patients. 16.1% of the patients carried homozygous genotypes while 83.9% of patients carried compound heterozygous mutations. We concluded that the frequency of CYP21A2 mutations in our study was slightly different from those reported for other ethnic groups. Micro-conversions were the main category of the mutation spectrum, while large deletions and large gene conversions could also cause 21-OHD. A large portion of different types of the compound heterozygous genotypes may partially contribute to the discordance in genotype-phenotype comparison. This study expanded the CYP21A2 mutation spectrum of Chinese patients and could be helpful in prenatal diagnosis and genetic counseling for 21-OHD patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  21-Hydroxylase deficiency; CYP21A2 gene; Congenital adrenal hyperplasia; Genotype–phenotype correlation; Mutational spectrum

Mesh:

Substances:

Year:  2016        PMID: 26804566     DOI: 10.1016/j.steroids.2016.01.007

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  15 in total

1.  Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.

Authors:  Mayara Jorgens Prado; Simone Martins de Castro; Cristiane Kopacek; Maricilda Palandi de Mello; Thaiane Rispoli; Tarciana Grandi; Cláudia Maria Dornelles da Silva; Maria Lucia Rosa Rossetti
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 2.  Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Mirjana Kocova; Violeta Anastasovska; Henrik Falhammar
Journal:  Endocrine       Date:  2020-05-05       Impact factor: 3.633

3.  Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.

Authors:  Chao Xu; Wenyu Jia; Xiangdeng Cheng; Hui Ying; Jing Chen; Jin Xu; Qingbo Guan; Xinli Zhou; Dongmei Zheng; Guimei Li; Jiajun Zhao
Journal:  Mol Genet Genomic Med       Date:  2019-04-09       Impact factor: 2.183

4.  Neonatal Screening and Genotype-Phenotype Correlation of 21-Hydroxylase Deficiency in the Chinese Population.

Authors:  Xin Wang; Yanyun Wang; Dingyuan Ma; Zhilei Zhang; Yahong Li; Peiying Yang; Yun Sun; Tao Jiang
Journal:  Front Genet       Date:  2021-01-22       Impact factor: 4.599

5.  CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica.

Authors:  Andrés Umaña-Calderón; María José Acuña-Navas; Danny Alvarado; Mildred Jiménez; Fred Cavallo-Aita
Journal:  Mol Genet Metab Rep       Date:  2021-02-09

6.  Genetic aetiology of primary adrenal insufficiency in Chinese children.

Authors:  Zhuo Chang; Wei Lu; Zhuhui Zhao; Li Xi; Xiaojing Li; Rong Ye; Jinwen Ni; Zhou Pei; Miaoying Zhang; Ruoqian Cheng; Zhangqian Zheng; Chengjun Sun; Jing Wu; Feihong Luo
Journal:  BMC Med Genomics       Date:  2021-06-30       Impact factor: 3.063

7.  Structure-based activity prediction of CYP21A2 stability variants: A survey of available gene variations.

Authors:  Carlos D Bruque; Marisol Delea; Cecilia S Fernández; Juan V Orza; Melisa Taboas; Noemí Buzzalino; Lucía D Espeche; Andrea Solari; Verónica Luccerini; Liliana Alba; Alejandro D Nadra; Liliana Dain
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

8.  Phenotype heterogeneity of congenital adrenal hyperplasia due to genetic mosaicism and concomitant nephrogenic diabetes insipidus in a sibling.

Authors:  Yılmaz Kor; Minjing Zou; Roua A Al-Rijjal; Dorota Monies; Brian F Meyer; Yufei Shi
Journal:  BMC Med Genet       Date:  2018-07-11       Impact factor: 2.103

9.  Severe Congenital Adrenal Hyperplasia Presenting as Bilateral Testicular Tumors and Azoospermia in the Third Decade of Life.

Authors:  Julie Sarfati; Camille Vatier; Isabelle Keller; Jérome Guéchot; Christine Bellanné-Chantelot; Sophie Christin-Maitre
Journal:  J Endocr Soc       Date:  2018-07-04

10.  The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l-hydroxylase deficiency in a Chinese cohort.

Authors:  Yang Liu; Jie Zheng; Nan Liu; Xiaowei Xu; Xinjie Zhang; Ying Zhang; Guoxu Li; Geli Liu; Chunquan Cai; Jianbo Shu
Journal:  Mol Genet Genomic Med       Date:  2020-09-21       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.